생명과학회지 (Journal of Life Science)

  • 제29권12호
  • /
  • Pages.1329-1336
  • /
  • 2019
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

미토콘드리아 저해제인 rotenone의 일시적 처리가 쥐의 뇌실 하 영역 신경 줄기 세포에 미치는 영향

Effects of Transient Treatment with Rotenone, a Mitochondrial Inhibitor, on Mouse Subventricular Zone Neural Stem Cells

  • 박기엽 (KAIST 부설 한국과학영재학교) ;
  • 김만수 (인제대학교 약학대학)
  • 투고 : 2019.11.20
  • 심사 : 2019.12.11
  • 발행 : 2019.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

뇌에서 뇌실하 영역은 자가 복제 및 신경세포와 교세포로 분화하는 신경줄기세포가 위치한 곳이다. 이러한 신경줄기세포는 태어난 직후 뿐만 아니라, 성인기까지 존재한다. 세포 증식과 분화에 대한 결정은 세포 안과 밖의 상황에 따라 조절될 필요가 있기에, 많은 세포 내부 또는 세포 외부의 인자들이 이러한 결정에 관여한다. 이러한 인자들 중에서 미토콘드리아는 신경줄기세포의 운명 결정에 관여함이 보고된 바 있다. 본 저자들의 이전 논문에서, 미토콘드리아 저해제인 rotenone을 장시간 처리했을 때, 신경세포로의 분화가 거의 일어나지 않았음을 보여주었다. 이번 연구에서, rotenone을 뇌실하 영역 신경줄기세포에 단기간 처리했을 때의 영향에 대해 조사하였다. 이를 통해 다음과 같은 결과를 관찰하였다. (1) 하루 동안 rotenone을 처리하자 신경세포로의 분화가 크게 감소하였고, 특히 분화 초기 단계가 더 민감하게 억제되었다. (2) 일시적 증식세포인 Mash1+ 세포의 수가 rotenone을 하루 처리한 후 감소하였다. (3) 분화가 된 Tuj1+ 신경세포와 Olig2+ 희소 돌기 아교 세포 (oligodendrocytes) 모두 rotenone을 단기간 처리하자 감소하였다. 반면, glial fibrillary acidic protein (GFAP)+성상 세포 (astrocytes)의 수는 변화하지 않았다. (4) sulfiredoxin 1 (Srxn1) 유전자 발현이 rotenone을 하루 처리한 후 증가하였는데, 이는 nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 신호전달 경로가 활성화 되었음을 말해준다. 이러한 실험 결과는 기능을 갖춘 미토콘드리아가 신경세포 또는 희소 돌기 아교 세포로의 분화 뿐 아니라, 이미 분화가 끝난 신경세포의 유지에도 필요함을 확인해 주었다. 또한, 이러한 결과는 rotenone과 같은 미토콘드리아의 저해제에 짧은 시간 노출 되더라도 신경줄기세포의 신경세포로의 분화 가능성에 장기적인 영향을 미칠 수 있음을 시사한다.

Subventricular zone (SVZ) in the brain contains neural stem cells (NSCs) which self-renew and differentiate to neurons and glial cells during postnatal period and throughout adulthood. Since fate decision to either proliferation or differentiation has to respond to intracellular and extracellular conditions, many intrinsic and extrinsic factors are involved. Among them, mitochondria have been reported to participate in fate decision of NSCs. In our previous report, we showed that long-term treatment of a mitochondrial inhibitor rotenone greatly inhibited neurogenesis. In this study, we examined the effects of short-term treatment of rotenone on SVZ NSCs. We found that (1) even one-day treatment of rotenone significantly reduced neurogenesis and earlier time points seemed to be more sensitive to rotenone, (2) a number of Mash1+ transit amplifying cells was decreased by one-day treatment of rotenone, (3) short-term treatment of rotenone eliminated most of the differentiated Tuj1+ neurons and Olig2+ oligodendrocytes, while glial fibrillary acidic protein (GFAP)+ astrocytes were not affected, and (4) sulfiredoxin 1 (Srxn1) gene expression was increased after one-day treatment of rotenone, indicating activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway. All these results confirm that functional mitochondria are necessary during differentiation to neurons or oligodendrocytes as well as maintenance of neurons after differentiation. Also, these data suggest that temporary exposure to mitochondrial inhibitor such as rotenone might have long-term effects on neurogenic potential of NSCs.

키워드

참고문헌

  1. Bertrand, N., Castro, D. S. and Guillemot, F. 2002. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517-530. https://doi.org/10.1038/nrn874
  2. Cabello-Rivera, D., Sarmiento-Soto, H., Lopez-Barneo, J. and Munoz-Cabello, A. M. 2019. Mitochondrial complex i function is essential for neural stem/progenitor cells proliferation and differentiation. Front. Neurosci. 13, 664. https://doi.org/10.3389/fnins.2019.00664
  3. Cabezas, R., Avila, M. F., Gonzalez, J., El-Bacha, R. S. and Barreto, G. E. 2015. Pdgf-bb protects mitochondria from rotenone in t98g cells. Neurotox. Res. 27, 355-367. https://doi.org/10.1007/s12640-014-9509-5
  4. Cabezas, R., Vega-Vela, N. E., Gonzalez-Sanmiguel, J., Gonzalez, J., Esquinas, P., Echeverria, V. and Barreto, G. E. 2018. Pdgf-bb preserves mitochondrial morphology, attenuates ros production, and upregulates neuroglobin in an astrocytic model under rotenone insult. Mol. Neurobiol. 55, 3085-3095. https://doi.org/10.1007/s12035-017-0567-6
  5. Choi, S. Y., Kim, J. Y., Kim, H. W., Cho, B., Cho, H. M., Oppenheim, R. W., Kim, H., Rhyu, I. J. and Sun, W. 2013. Drp1-mediated mitochondrial dynamics and survival of developing chick motoneurons during the period of normal programmed cell death. FASEB J. 27, 51-62. https://doi.org/10.1096/fj.12-211920
  6. Corenblum, M. J., Ray, S., Remley, Q. W., Long, M., Harder, B., Zhang, D. D., Barnes, C. A. and Madhavan, L. 2016. Reduced nrf2 expression mediates the decline in neural stem cell function during a critical middle-age period. Aging Cell 15, 725-736. https://doi.org/10.1111/acel.12482
  7. Hayes, J. D., McMahon, M., Chowdhry, S. and Dinkova-Kostova, A. T. 2010. Cancer chemoprevention mechanisms mediated through the keap1-nrf2 pathway. Antioxid. Redox Signal. 13, 1713-1748. https://doi.org/10.1089/ars.2010.3221
  8. Park, K. Y. and Kim, M. S. 2018. Inhibition of proliferation and neurogenesis of mouse subventricular zone neural stem cells by a mitochondrial inhibitor rotenone. J. Life Sci. 28, 1397-1405. https://doi.org/10.5352/jls.2018.28.12.1397
  9. Kim, E. J., Ables, J. L., Dickel, L. K., Eisch, A. J. and Johnson, J. E. 2011. Ascl1 (mash1) defines cells with long-term neurogenic potential in subgranular and subventricular zones in adult mouse brain. PLoS One 6, e18472. https://doi.org/10.1371/journal.pone.0018472
  10. Kim, H. J., Shaker, M. R., Cho, B., Cho, H. M., Kim, H., Kim, J. Y. and Sun, W. 2015. Dynamin-related protein 1 controls the migration and neuronal differentiation of subventricular zone-derived neural progenitor cells. Sci. Rep. 5, 15962. https://doi.org/10.1038/srep15962
  11. Krug, A. K., Balmer, N. V., Matt, F., Schonenberger, F., Merhof, D. and Leist, M. 2013. Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch. Toxicol. 87, 2215-2231. https://doi.org/10.1007/s00204-013-1072-y
  12. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Impagnatiello, F., Pluchino, S. and Marchetti, B. 2013. Aging-induced nrf2-are pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via pi3k-wnt/beta-catenin dysregulation. J. Neurosci. 33, 1462-1485. https://doi.org/10.1523/JNEUROSCI.3206-12.2013
  13. Lim, D. A. and Alvarez-Buylla, A. 2016. The adult ventricular-subventricular zone (v-svz) and olfactory bulb (ob) neurogenesis. Cold Spring Harb. Perspect. Biol. 8, a018820. https://doi.org/10.1101/cshperspect.a018820
  14. Lu, J., Li, Y., Mollinari, C., Garaci, E., Merlo, D. and Pei, G. 2019. Amyloid-beta oligomers-induced mitochondrial DNA repair impairment contributes to altered human neural stem cell differentiation. Curr. Alzheimer Res. 16, 934-949. https://doi.org/10.2174/1567205016666191023104036
  15. Ma, Q. 2013. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53, 401-426. https://doi.org/10.1146/annurev-pharmtox-011112-140320
  16. Nakatani, H., Martin, E., Hassani, H., Clavairoly, A., Maire, C. L., Viadieu, A., Kerninon, C., Delmasure, A., Frah, M., Weber, M., Nakafuku, M., Zalc, B., Thomas, J. L., Guillemot, F., Nait-Oumesmar, B. and Parras, C. 2013. Ascl1/mash1 promotes brain oligodendrogenesis during myelination and remyelination. J. Neurosci. 33, 9752-9768. https://doi.org/10.1523/JNEUROSCI.0805-13.2013
  17. Nguyen, H. T. N., Kato, H., Masuda, K., Yamaza, H., Hirofuji, Y., Sato, H., Pham, T. T. M., Takayama, F., Sakai, Y., Ohga, S., Taguchi, T. and Nonaka, K. 2018. Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of children with autism spectrum disorder. Biochem. Biophys. Rep. 16, 24-31.
  18. Parras, C. M., Galli, R., Britz, O., Soares, S., Galichet, C., Battiste, J., Johnson, J. E., Nakafuku, M., Vescovi, A. and Guillemot, F. 2004. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. EMBO J. 23, 4495-4505. https://doi.org/10.1038/sj.emboj.7600447
  19. Pistollato, F., Canovas-Jorda, D., Zagoura, D. and Bal-Price, A. 2017. Nrf2 pathway activation upon rotenone treatment in human ipsc-derived neural stem cells undergoing differentiation towards neurons and astrocytes. Neurochem. Int. 108, 457-471. https://doi.org/10.1016/j.neuint.2017.06.006
  20. Ray, S., Corenblum, M. J., Anandhan, A., Reed, A., Ortiz, F. O., Zhang, D. D., Barnes, C. A. and Madhavan, L. 2018. A role for nrf2 expression in defining the aging of hippocampal neural stem cells. Cell Transplant. 27, 589-606. https://doi.org/10.1177/0963689718774030
  21. Richetin, K., Moulis, M., Millet, A., Arrazola, M. S., Andraini, T., Hua, J., Davezac, N., Roybon, L., Belenguer, P., Miquel, M. C. and Rampon, C. 2017. Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of alzheimer's disease. Neurobiol. Dis. 102, 113-124. https://doi.org/10.1016/j.nbd.2017.03.002
  22. Shaw, P. and Chattopadhyay, A. 2019. Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms. J. Cell. Physiol. doi:10.1002/jcp.29219.
  23. Son, G. and Han, J. 2018. Roles of mitochondria in neuronal development. BMB Rep. 51, 549-556. https://doi.org/10.5483/BMBRep.2018.51.11.226
  24. von Wrangel, C., Schwabe, K., John, N., Krauss, J. K. and Alam, M. 2015. The rotenone-induced rat model of parkinson's disease: Behavioral and electrophysiological findings. Behav. Brain Res. 279, 52-61. https://doi.org/10.1016/j.bbr.2014.11.002
  25. Walter, J., Bolognin, S., Antony, P. M. A., Nickels, S. L., Poovathingal, S. K., Salamanca, L., Magni, S., Perfeito, R., Hoel, F., Qing, X., Jarazo, J., Arias-Fuenzalida, J., Ignac, T., Monzel, A. S., Gonzalez-Cano, L., Pereira de Almeida, L., Skupin, A., Tronstad, K. J. and Schwamborn, J. C. 2019. Neural stem cells of parkinson's disease patients exhibit aberrant mitochondrial morphology and functionality. Stem Cell Reports 12, 878-889. https://doi.org/10.1016/j.stemcr.2019.03.004
  26. Wu, J., Chen, Y., Yu, S., Li, L., Zhao, X., Li, Q., Zhao, J. and Zhao, Y. 2017. Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. Brain Res. Bull. 132, 99-108. https://doi.org/10.1016/j.brainresbull.2017.05.012
  27. Zhou, Y., Duan, S., Zhou, Y., Yu, S., Wu, J., Wu, X., Zhao, J. and Zhao, Y. 2015. Sulfiredoxin-1 attenuates oxidative stress via nrf2/are pathway and 2-cys prdxs after oxygenglucose deprivation in astrocytes. J. Mol. Neurosci. 55, 941-950. https://doi.org/10.1007/s12031-014-0449-6